Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 9 December 2025

Rigetti Computing (RGTI) Stock News Today: DARPA Setback, Citadel Buying and 2026–2030 Forecasts

Rigetti Computing (RGTI) Stock News Today: DARPA Setback, Citadel Buying and 2026–2030 Forecasts

As of December 9, 2025, Rigetti Computing, Inc. (NASDAQ: RGTI) remains one of the wildest rides in quantum computing. The stock is trading around $27–28 per share, with intraday moves between roughly $26.9 and $28.2, implying a market cap just under $10 billion on trailing 12‑month revenue of only about $7.5 million. StockAnalysis Over the past year, Rigetti’s share price has gone parabolic and then some—up roughly 586% over the last 52 weeks by one hedge fund’s tally and around 3,750% since January 2023—yet the stock also collapsed about 42% in November after a messy third‑quarter report and a harsh
9 December 2025
···
Disney Stock (DIS) on December 9, 2025: Big-Money Moves, Q4 Fallout and 2026–2028 Forecasts

Disney Stock (DIS) on December 9, 2025: Big-Money Moves, Q4 Fallout and 2026–2028 Forecasts

Ticker: NYSE: DISDate: December 9, 2025 The Walt Disney Company’s stock is trading in a tight range just above key support as Wall Street digests mixed fiscal 2025 results, a looming YouTube TV dispute and fresh analyst forecasts that still point to double‑digit earnings growth over the next few years. Disney stock price and valuation today As of late trading on December 9, 2025, Disney shares change hands at about $107 per share, down roughly 0.5% on the day, after opening near $107.50 and trading between about $106.6 and $107.9. Key valuation and balance‑sheet metrics from recent filings and analyst
9 December 2025
··
Snowflake (SNOW) Stock on December 9, 2025: Is the Post‑Earnings Dip a Buying Opportunity?

Snowflake (SNOW) Stock on December 9, 2025: Is the Post‑Earnings Dip a Buying Opportunity?

Snowflake Inc. (NYSE: SNOW) has spent the past week digesting a sharp post‑earnings sell‑off, even as its AI‑driven growth story and free‑cash‑flow (FCF) guidance continue to impress Wall Street. As of late trading on December 9, 2025, Snowflake shares change hands around $222 per share, giving the company a market capitalization in the mid‑$70 billion range.MacroTrends+1 That’s roughly 15–20% below last week’s pre‑earnings high near $265, but still leaves the stock up strongly for 2025 — more than 60–70% year to date, according to multiple reports.Reuters+1 Below is a comprehensive look at today’s key news (09.12.2025), recent earnings, analyst forecasts,
9 December 2025
··
CrowdStrike Stock (CRWD) on December 9, 2025: Price Action, AI Deals, Analyst Targets and 2026 Outlook

CrowdStrike Stock (CRWD) on December 9, 2025: Price Action, AI Deals, Analyst Targets and 2026 Outlook

CrowdStrike Holdings, Inc. (NASDAQ: CRWD) continues to sit at the center of three powerful themes on December 9, 2025: cybersecurity, artificial intelligence and cloud infrastructure. The stock is back above the $520 mark after a volatile reaction to its latest earnings report, while Wall Street keeps raising price targets even as some traders warn about stretched valuations. Below is a full rundown of where the stock stands today, what just happened in Q3, and how major analysts and institutions see CrowdStrike heading into 2026. Where CrowdStrike Stock Trades Today In early afternoon trading on December 9, 2025, CrowdStrike shares change
9 December 2025
····
Chevron (CVX) Stock on December 9, 2025: Latest News, Analyst Forecasts, Dividend and 2030 Outlook

Chevron (CVX) Stock on December 9, 2025: Latest News, Analyst Forecasts, Dividend and 2030 Outlook

Published: December 9, 2025 Chevron Corporation (NYSE: CVX) traded around $148–$149 per share on Tuesday, down fractionally on the day, leaving the oil major roughly in the middle of its 52‑week range of $132 to $169. At this level, the stock carries a price‑to‑earnings ratio near 21, a dividend yield of about 4.6%, and a market capitalization just under $300 billion. Benzinga+1 Investors today are digesting fresh 2026 capital‑spending guidance, a detailed 2030 cash‑flow roadmap, new upstream projects in Australia and Nigeria, and ongoing integration of the $55 billion Hess acquisition, all against a backdrop of mixed short‑term technical signals
9 December 2025
··
Walmart (WMT) Stock on December 9, 2025: Nasdaq Debut, Tech Pivot and 2026 Outlook

Walmart (WMT) Stock on December 9, 2025: Nasdaq Debut, Tech Pivot and 2026 Outlook

On December 9, 2025, Walmart Inc. stock begins trading on the Nasdaq, capping a year in which the world’s largest retailer by revenue has quietly turned into one of Wall Street’s favorite “tech‑adjacent” growth stories. With WMT hovering around $114 per share, a market value of roughly $910 billion and a price‑to‑earnings multiple near 40x, investors are asking the same question: how much of Walmart’s future is already priced in – and what comes next for the stock? StockAnalysis+1 Walmart stock today: price, valuation and trading range As of mid‑day trading on December 9, 2025, Walmart (ticker: WMT) is changing
9 December 2025
··
Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson stock (NYSE: JNJ) has quietly turned into one of 2025’s standout blue‑chip winners. As of December 9, 2025, JNJ trades around $202 per share, valuing the company at roughly $486 billion and leaving the stock up close to 40% year to date.Trefis+1 That move reflects more than just a defensive bid for a safe dividend name. Investors are reacting to a powerful combination of: Below is a detailed, news‑driven look at what’s moving Johnson & Johnson stock on December 9, 2025, and how Wall Street currently values and forecasts JNJ. Johnson & Johnson stock today: price, performance
9 December 2025
··
Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce, Inc. (NYSE: CRM) is back in the spotlight after reporting record fiscal Q3 2026 results, raising its full‑year outlook, and drawing a wave of analyst and institutional attention. As of December 9, 2025, Salesforce stock is trading around $260 per share, recovering sharply from recent lows but still well below its 52‑week high. MarketBeat This article pulls together all the key news, forecasts and analyses available on December 9, 2025 to give you a current, Google‑News‑ready view of Salesforce’s stock story — from AI and Agentforce to price targets, insider trades, dividends and risks. Salesforce stock price today: CRM
9 December 2025
··
JPMorgan Chase (JPM) Stock in December 2025: Price, Latest News, Analyst Forecasts and Key Risks

JPMorgan Chase (JPM) Stock in December 2025: Price, Latest News, Analyst Forecasts and Key Risks

JPMorgan Chase & Co. (NYSE: JPM) is ending 2025 near record highs and at the center of several major strategic moves – from a $1.5 trillion national‑security financing push to mutual‑fund‑to‑ETF conversions and a landmark crypto IPO mandate. Here’s a detailed look at where JPM stock stands on 9 December 2025, what the latest news means, and how Wall Street is valuing the world’s largest U.S. bank. 1. JPMorgan Chase Stock Today: Price, Valuation and Performance As of the latest real‑time data on 9 December 2025, JPMorgan Chase trades around $317 per share, with the prior close at $315.21. The
9 December 2025
·
Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma A/S (NASDAQ: ASND) is back in the spotlight on December 9, 2025, after its share price slipped again while Wall Street continues to project hefty upside and label the name a “Buy” or “Strong Buy.” The Danish biotech, known for its TransCon long-acting prodrug platform and endocrine rare disease franchise, is wrestling with three forces at once: Let’s unpack what’s going on with Ascendis Pharma stock today, how the story changed in recent weeks, and what current forecasts say about where ASND could go next. ASND stock today: price action and context By late trading on December 9,
9 December 2025
··
BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) is back in the spotlight on December 9, 2025, as the Ethereum‑focused treasury stock jumps roughly 8% intraday after confirming it now controls about 3.86 million ETH—more than 3.2% of all Ethereum in circulation—and a combined crypto and cash hoard of roughly $13.2 billion. Nasdaq+1 The rally caps a frantic few weeks that have included: Below is a deep dive into what’s happening with BMNR today, how the business model has evolved, and what current forecasts and analyses are actually saying. BMNR stock today: price, valuation and volatility snapshot As of the afternoon
9 December 2025
····
KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

Published 9 December 2025 KE Holdings Inc. (NYSE: BEKE), the Chinese online and offline housing platform behind Lianjia and Beike, is back in the spotlight as its stock trades lower today despite aggressive share repurchases and steady revenue growth. On Tuesday, BEKE gapped down at the open, sliding from a previous close of about $17.08 to an open near $16.35, with intraday trading around $16.27 and more than 1 million shares changing hands.MarketBeat In parallel, a Nasdaq/ETF Channel note highlighted that BEKE was among the notable decliners inside the Vanguard Total International Stock ETF (VXUS), with the stock down roughly
9 December 2025
····
Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics Inc. (NASDAQ: SMMT) continues to trade like a classic high-beta biotech: big promises in lung cancer, plenty of red flags, and a stock price stuck near the lower end of its 52-week range while analysts project eye-popping upside. As of the latest US session on December 9, 2025, SMMT is trading around $17–18 per share, versus a 52-week range of $15.55 to $36.91. That means the stock is much closer to its lows than its highs, despite a steady drumbeat of bullish analyst targets and positive trial headlines. Yahoo Finance+1 Below is a rundown of the most current
9 December 2025
·
Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group Holding Ltd (NASDAQ: CRDO) has turned into one of the most closely watched semiconductor names of late, thanks to explosive earnings growth and its strategic position in high-speed connectivity for AI data centers. As of 9 December 2025, the stock is trading around $168–170 per share, down from a recent all-time high above $210 but still miles above its 52-week low near $29. Investing.com In this deep dive, we’ll walk through the latest news, earnings, analyst forecasts, and key risks so you can understand why CRDO is suddenly everywhere in markets coverage. 1. Where CRDO Stands Today
9 December 2025
··
Linde plc (LIN) Stock on December 9, 2025: 52‑Week Low, CEO Buying and Double‑Digit Upside Price Targets

Linde plc (LIN) Stock on December 9, 2025: 52‑Week Low, CEO Buying and Double‑Digit Upside Price Targets

Linde plc (NASDAQ: LIN), the world’s largest industrial gases company, is having a pivotal moment in the market. On December 9, 2025, the stock is trading near fresh 52‑week lows at the same time its CEO is buying nearly $1 million worth of shares, short interest is creeping higher, and Wall Street still sees sizeable upside over the next 12 months. Below is a full roundup of today’s news, forecasts, and analysis — plus what it all could mean for Linde stock. Key takeaways for Linde stock today (9 December 2025) Linde stock price action on December 9, 2025 Market
9 December 2025
·
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) has quietly turned into one of 2025’s wilder biotech stories: a tiny oncology name that’s run more than eightfold off its 52-week low, pulled back on a big equity raise, and now sits in the middle of a high-stakes bet on a single breast-cancer drug. Below is a structured look at OLMA stock today, the latest news, Street forecasts, and the key risks investors are debating as of December 9, 2025. OLMA stock today: price, performance and volatility As of the latest trade on December 9, 2025, Olema Pharmaceuticals shares change hands at around $26–27
9 December 2025
·
Legend Biotech (LEGN) Stock Hits New Lows: Oversold CAR-T Leader or Long-Term Opportunity?

Legend Biotech (LEGN) Stock Hits New Lows: Oversold CAR-T Leader or Long-Term Opportunity?

As of December 9, 2025, shares of Legend Biotech Corporation (NASDAQ: LEGN) are under heavy pressure even as the company posts strong growth from its flagship CAR-T therapy, CARVYKTI. Here’s a deep dive into the latest news, forecasts, analyst calls and technical signals that are driving sentiment around Legend Biotech stock today. Where Legend Biotech Stock Trades Now Legend Biotech’s American Depositary Shares (ADS) were recently trading around $24.1, down roughly 8% on the day and hovering near fresh 52-week lows. Benzinga On December 9, 2025, the stock: A company news brief from Investing.com highlighted that Legend Biotech shares hit
9 December 2025
·
Waystar Holding Corp (WAY) Hits 52-Week Low as Barclays Cuts Target – But Wall Street Still Sees Big Upside

Waystar Holding Corp (WAY) Hits 52-Week Low as Barclays Cuts Target – But Wall Street Still Sees Big Upside

December 9, 2025 Waystar Holding Corp (NASDAQ: WAY), the healthcare payments software provider, is back in the spotlight after a sharp sell-off pushed the stock to fresh 52-week lows on Tuesday, even as Wall Street analysts continue to project substantial upside over the next 12 months. Waystar Stock Today: Fresh Lows in a Volatile Session In Tuesday’s trading, Waystar shares slid to the low-$31 range, marking a new 52-week low and extending a multi-month downtrend. Intraday, the stock traded between roughly $31 and $33, down about 6% on the day and hovering just above its one-year low around $30.75.StockAnalysis+1 According
9 December 2025
·
Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Newport News, VA – December 9, 2025 Ferguson Enterprises Inc. (NYSE: FERG; LSE: FERG) shares are under pressure today after the company reported results for the quarter ended October 31, 2025 (its fiscal Q1 2026). The numbers show solid operational momentum and raised full-year guidance, but the stock is trading sharply lower as investors digest valuations and future growth expectations. Below is a deep dive into today’s earnings, market reaction, analyst forecasts, and what it could mean for Ferguson stock going into 2026. 1. What Ferguson Reported Today Ferguson’s latest quarter was, in pure fundamental terms, strong: The company attributed
9 December 2025
···
Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging Holding Company (NYSE: GPK) — a major player in sustainable consumer packaging — is having a rough day on Wall Street. As of December 9, 2025, the stock has slid to a new 52-week low after the company cut its full-year earnings outlook, announced cost and production optimization measures, and confirmed a CEO transition set for early 2026. Investing.com India+1 Below is a detailed look at what’s happening with GPK stock today, the latest company news, analyst forecasts, and what the current market narrative looks like. GPK Stock Today: New 52-Week Low and Heavy Trading On December 9,
9 December 2025
··
1 … 844 845 846 847 848 … 1,175

Stock Market Today

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

8 February 2026
Deutsche Telekom shares fell 1.1% to 30.26 euros Friday, despite the company repurchasing 250,873 shares for about 7.63 million euros on Xetra. The drop came as European stocks rose and T-Mobile US shares slipped 2.2%. Deutsche Telekom’s 2025 results are due Feb. 26. The company has completed its 2025 buyback and launched a new 2 billion euro programme for 2026.
Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

8 February 2026
Airbus shares rose 0.94% to 191.30 euros Friday as the company reported 19 aircraft deliveries in January, down from 25 a year earlier. Supply chain bottlenecks remain an issue, with executives at the Singapore Airshow calling delays “unacceptable.” Jefferies kept a Neutral rating and a 215-euro price target. Airbus will report full-year 2025 results on Feb. 19.
Go toTop